Gilead's twice-yearly HIV prevention shot was 100% effective in women and almost as good in men. The company will offer cheap generic versions in 120 poor countries, mostly in Africa and Asia. However, it has excluded most of Latin America, raising concerns about missed opportunities to stop the disease in these regions. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
